HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.

Abstract
Hypoxia-inducible factor-1 alpha (HIF-1 alpha) and the aryl hydrocarbon receptor (AhR) work as environmental sensors in human tissues. These proteins are members of the helix-loop-helix/Per-ARNT-SIM transcription factor family and form heterodimers with the aryl hydrocarbon receptor nuclear translocator. HIF-1 alpha can be activated by low oxygen concentrations and hypoxia-inducing agents. The AhR is activated by xenobiotica such as dioxins. Here, we analyze the interference between the AhR signaling, activated by 10 nM 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD), and the HIF-1 alpha pathway, induced by hypoxia (5% O2), in two human cell lines, the breast carcinoma cell line MCF-7 and the hepatocyte cell line HepG2. In both cell lines, treatment with TCDD and hypoxia clearly reduced the stabilization of HIF-1 alpha and HRE-mediated promoter activity when compared to the induction under hypoxia alone. Because these effects were not observed after alpha-naphthoflavone treatment and HIF-1 alpha mRNA was not down-regulated, HIF-1 alpha stabilization was revealed to be the target by TCDD in an AhR-depended mechanism. Under exposure to TCDD or hypoxia, the main regulator of HIF-1 alpha stability, the prolyl hydroxylase domain containing protein 2 (PHD2) showed an increase in promoter activity, transcript numbers, and protein amount. Therefore, PHD2 expression is regulated in an AhR-dependent manner under normoxia. The AhR-dependent regulation of PHD2 under normoxia, however, is overwritten by the TCDD-mediated destabilization of HIF-1 alpha. The destabilization of HIF-1 alpha is the dominant effect causing the reduced PHD2 expression after simultaneous exposure to TCDD and hypoxia. We conclude that PHD2 does not mediate the TCDD-mediated HIF-1 alpha destabilization and does not control the interference of AhR and HIF-1 alpha pathways.
AuthorsAnja Seifert, Dörthe M Katschinski, Sarah Tonack, Bernd Fischer, Anne Navarrete Santos
JournalChemical research in toxicology (Chem Res Toxicol) Vol. 21 Issue 2 Pg. 341-8 (Feb 2008) ISSN: 0893-228X [Print] United States
PMID18072750 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzoflavones
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Polychlorinated Dibenzodioxins
  • RNA, Messenger
  • Receptors, Aryl Hydrocarbon
  • alpha-naphthoflavone
  • EGLN1 protein, human
  • Procollagen-Proline Dioxygenase
  • Hypoxia-Inducible Factor-Proline Dioxygenases
Topics
  • Benzoflavones (pharmacology)
  • Breast Neoplasms
  • Carcinoma, Hepatocellular
  • Cell Hypoxia (physiology)
  • Cell Line, Tumor
  • Down-Regulation
  • Gene Expression Regulation (drug effects)
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Liver Neoplasms
  • Polychlorinated Dibenzodioxins (toxicity)
  • Procollagen-Proline Dioxygenase (metabolism)
  • RNA, Messenger (metabolism)
  • Receptors, Aryl Hydrocarbon (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: